BridgeBio Oncology Therapeutics
BBOT | NASDAQ
$1.98
-$0.16 (-7.48%)
At close: Nov 16, 2026, 4:00 PM ET
$2.01
+$0.03 (+1.52%)
After-hours:
Nov 16, 2026, 7:00 PM ET
BridgeBio Oncology Therapeutics Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net InflowTotal Institutions
67
Total Ownership
74219.11%
Capital Flow
+$61.06M
Shares Change
+1.98M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
18
Increased Positions
39
Reduced Positions
14
Closed Positions
18
New (18)
Increased (39)
Reduced (14)
Closed (18)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Moore Capital Management LP | 124.92% 0.00% | 0.02% | 100K | 923K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 22333.17% -0.03% | 6.98% -13.13% | 17.88M 0.00% | 136.23M -14.86% | |
| Deerfield Management Company, L.p. | 6102.69% -0.03% | 0.39% -24.72% | 4.89M 0.00% | 37.23M -14.86% | |
| Omega Fund Management, LLC | 4109.30% -0.03% | 13.50% -25.19% | 3.29M 0.00% | 25.07M -14.86% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove BBOT